Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF
 
research article

The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF

Tardivel, A.
•
Tinel, A.
•
Lens, S.
Show more
2004
European Journal of Immunology

The TNF family ligand B cell-activating factor (BAFF, BLyS, TALL-1) is an essential factor for B cell development. BAFF binds to three receptors, BAFF-R, transmembrane activator and CAML interactor (TACI), and B cell maturation antigen (BCMA), but only BAFF-R is required for successful survival and maturation of splenic B cells. To test whether the effect of BAFF is due to the up-regulation of anti-apoptotic factors, TACI-Ig-transgenic mice, in which BAFF function is inhibited, were crossed with transgenic mice expressing FLICE-inhibitory protein (FLIP) or Bcl-2 in the B cell compartment. FLIP expression did not rescue B cells, while enforced Bcl-2 expression restored peripheral B cells and the ability to mount T-dependent antibody responses. However, many B cells retained immaturity markers and failed to express normal amounts of CD21. Marginal zone B cells were not restored and the T-independent IgG3, but not IgM, response was impaired in the TACI-IgxBcl-2 mice. These results suggest that BAFF is required not only to inhibit apoptosis of maturating B cells, but also to promote differentiation events, in particular those leading to the generation of marginal zone B cells.

  • Details
  • Metrics
Type
research article
DOI
10.1002/eji.200324692
Author(s)
Tardivel, A.
Tinel, A.
Lens, S.
Steiner, Q. G.
Sauberli, E.
Wilson, A.
Mackay, F.
Rolink, A. G.
Beermann, F.  
Tschopp, J.
Show more
Date Issued

2004

Published in
European Journal of Immunology
Volume

34

Issue

2

Start page

509

End page

18

Note

Department of Biochemistry, BIL Biomedical Research Center, University of Lausanne, Epalinges, Switzerland.

Editorial or Peer reviewed

REVIEWED

Written at

OTHER

EPFL units
GR-BEERMANN  
Available on Infoscience
January 10, 2008
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/16072
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés